Healthcare provider profile · identity verified

Thomas Kevin Labruzzo, DO

Internal Medicine · NORTH KANSAS CITY, MO · NPI 1851363725

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	644	177
Amlodipine Besylate	Amlodipine Besylate	591	162
Levothyroxine Sodium	Levothyroxine Sodium	554	134
Rosuvastatin Calcium	Rosuvastatin Calcium	495	139
Losartan Potassium	Losartan Potassium	390	109
Lisinopril	Lisinopril	384	111
Metformin Hcl	Metformin Hcl	358	105
Gabapentin	Gabapentin	334	92
Omeprazole	Omeprazole	292	76
Pantoprazole Sodium	Pantoprazole Sodium	270	75
Metoprolol Succinate	Metoprolol Succinate	208	60
Alprazolam	Alprazolam	187	43
Potassium Chloride	Potassium Chloride	178	52
Tamsulosin Hcl	Tamsulosin Hcl	166	46
Furosemide	Furosemide	165	43
Pravastatin Sodium	Pravastatin Sodium	163	42
Escitalopram Oxalate	Escitalopram Oxalate	158	48
Albuterol Sulfate Hfa	Albuterol Sulfate	154	51
Hydrochlorothiazide	Hydrochlorothiazide	153	41
Tramadol Hcl	Tramadol Hcl	144	45
Metoprolol Tartrate	Metoprolol Tartrate	143	41
Carvedilol	Carvedilol	141	43
Famotidine	Famotidine	136	44
Montelukast Sodium	Montelukast Sodium	136	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	132	40
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	128	33
Sertraline Hcl	Sertraline Hcl	128	31
Trazodone Hcl	Trazodone Hcl	126	34
Alendronate Sodium	Alendronate Sodium	122	34
Eliquis	Apixaban	118	29
Metformin Hcl Er	Metformin Hcl	115	35
Clopidogrel	Clopidogrel Bisulfate	113	33
Simvastatin	Simvastatin	112	32
Ozempic	Semaglutide	103	22
Meloxicam	Meloxicam	93	20
Allopurinol	Allopurinol	91	26
Citalopram Hbr	Citalopram Hydrobromide	87	20
Zolpidem Tartrate	Zolpidem Tartrate	84	21
Ezetimibe	Ezetimibe	78	25
Duloxetine Hcl	Duloxetine Hcl	77	23
Jardiance	Empagliflozin	74	20
Glimepiride	Glimepiride	69	19
Synthroid	Levothyroxine Sodium	65	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	60	15
Januvia	Sitagliptin Phosphate	59	16
Azithromycin	Azithromycin	57	44
Donepezil Hcl	Donepezil Hcl	56	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	25
Fluticasone Propionate	Fluticasone Propionate	54	16
Finasteride	Finasteride	52	13
Venlafaxine Hcl Er	Venlafaxine Hcl	52	11
Bupropion Xl	Bupropion Hcl	50	13
Cephalexin	Cephalexin	48	29
Fenofibrate	Fenofibrate	46	11
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	12
Ibuprofen	Ibuprofen	45	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	43	43
Hydralazine Hcl	Hydralazine Hcl	43	13
Fluoxetine Hcl	Fluoxetine Hcl	42	12
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	11
Colestipol Hcl	Colestipol Hcl	41	11
Humalog Kwikpen U-100	Insulin Lispro	41	12
Methylprednisolone	Methylprednisolone	41	31
Shingrix	Varicella-Zoster Ge/As01b/Pf	41	30
Paroxetine Hcl	Paroxetine Hcl	39	11
Sildenafil Citrate	Sildenafil Citrate	39	suppressed
Spironolactone	Spironolactone	39	11
Atenolol	Atenolol	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	13
Benazepril Hcl	Benazepril Hcl	37	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	37	suppressed
Celecoxib	Celecoxib	36	suppressed
Naproxen	Naproxen	36	12
Pregabalin	Pregabalin	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	32
Levetiracetam	Levetiracetam	35	suppressed
Lorazepam	Lorazepam	35	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	34	34
Propranolol Hcl	Propranolol Hcl	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Prednisone	Prednisone	32	17
Clonazepam	Clonazepam	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	27
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	12
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Temazepam	Temazepam	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	19
Diazepam	Diazepam	23	suppressed
Glipizide	Glipizide	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Etodolac	Etodolac	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Ramipril	Ramipril	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	20
Enalapril Maleate	Enalapril Maleate	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Levofloxacin	Levofloxacin	17	14
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Nystatin	Nystatin	15	11
Topiramate	Topiramate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Colchicine	Colchicine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Digoxin	Digoxin	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error